TR199900157T2 - H�cre proliferasyon inhibisyonu i�in ikame edilmi� bisindolilmaleimidleri. - Google Patents

H�cre proliferasyon inhibisyonu i�in ikame edilmi� bisindolilmaleimidleri.

Info

Publication number
TR199900157T2
TR199900157T2 TR1999/00157T TR9900157T TR199900157T2 TR 199900157 T2 TR199900157 T2 TR 199900157T2 TR 1999/00157 T TR1999/00157 T TR 1999/00157T TR 9900157 T TR9900157 T TR 9900157T TR 199900157 T2 TR199900157 T2 TR 199900157T2
Authority
TR
Turkey
Prior art keywords
cell proliferation
proliferation inhibition
formula
bisindolylmaleimides
substituted
Prior art date
Application number
TR1999/00157T
Other languages
English (en)
Turkish (tr)
Inventor
Mary Huryn Donna
Dalton Keith Denn�S
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199900157T2 publication Critical patent/TR199900157T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
TR1999/00157T 1996-07-29 1997-07-19 H�cre proliferasyon inhibisyonu i�in ikame edilmi� bisindolilmaleimidleri. TR199900157T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29

Publications (1)

Publication Number Publication Date
TR199900157T2 true TR199900157T2 (xx) 1999-04-21

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/00157T TR199900157T2 (xx) 1996-07-29 1997-07-19 H�cre proliferasyon inhibisyonu i�in ikame edilmi� bisindolilmaleimidleri.

Country Status (23)

Country Link
US (2) US5856517A (enExample)
EP (1) EP0915872B1 (enExample)
JP (1) JP2000516589A (enExample)
KR (1) KR20000029637A (enExample)
CN (2) CN1151149C (enExample)
AR (1) AR008267A1 (enExample)
AT (1) ATE240318T1 (enExample)
AU (1) AU739742B2 (enExample)
BR (1) BR9711605A (enExample)
CA (1) CA2262092A1 (enExample)
CO (1) CO4900055A1 (enExample)
CY (1) CY2483B1 (enExample)
DE (1) DE69722003T2 (enExample)
DK (1) DK0915872T3 (enExample)
ES (1) ES2198001T3 (enExample)
HR (1) HRP970414A2 (enExample)
MA (1) MA24287A1 (enExample)
PE (1) PE91698A1 (enExample)
PT (1) PT915872E (enExample)
SA (1) SA97180473A (enExample)
TR (1) TR199900157T2 (enExample)
WO (1) WO1998004552A1 (enExample)
ZA (1) ZA976492B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20000585B1 (en) * 1998-03-17 2009-02-28 F. Hoffmann - La Roche Ag Substituted bisindolymaleimides for the inhibition of cell proliferation
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6867198B2 (en) 1999-12-16 2005-03-15 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
DE60010934T2 (de) * 1999-12-16 2005-05-19 Eli Lilly And Co., Indianapolis Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
US6281356B1 (en) 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TWI335221B (en) * 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
AR040083A1 (es) * 2002-05-22 2005-03-16 Smithkline Beecham Corp Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
DK1846406T5 (da) 2005-02-09 2011-10-31 Arqule Inc Maleimidderivater, farmaceutiske sammensætninger og fremgangsmåder til behandling af cancer
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
JP5490688B2 (ja) 2007-06-22 2014-05-14 アークル インコーポレイテッド 癌の治療のためのインドリルピロリジン
CA2690799C (en) 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
CN101801937A (zh) 2007-06-22 2010-08-11 艾科尔公司 喹唑啉酮化合物及其使用方法
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
CA2939219C (en) 2014-02-11 2023-02-28 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
EP3741375A1 (en) 2014-07-17 2020-11-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
KR20200019228A (ko) * 2017-06-21 2020-02-21 미토키닌, 인크. 신경퇴행성 및 미토콘드리아 질환의 치료를 위한 조성물 및 이를 사용하는 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK75289A3 (en) * 1988-02-10 1998-05-06 Hoffmann La Roche Substituted pyrroles, their use for producing a drug, and the drug on their base
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
AU3761393A (en) * 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
EP0915872B1 (en) 2003-05-14
AU3769097A (en) 1998-02-20
PE91698A1 (es) 1998-12-24
PT915872E (pt) 2003-09-30
ES2198001T3 (es) 2004-01-16
US5856517A (en) 1999-01-05
CA2262092A1 (en) 1998-02-05
WO1998004552A1 (en) 1998-02-05
MA24287A1 (fr) 1998-04-01
US6030994A (en) 2000-02-29
CO4900055A1 (es) 2000-03-27
DE69722003T2 (de) 2004-04-01
CN1151149C (zh) 2004-05-26
AR008267A1 (es) 1999-12-29
CN1495182A (zh) 2004-05-12
HRP970414A2 (en) 1998-06-30
ATE240318T1 (de) 2003-05-15
DK0915872T3 (da) 2003-09-08
AU739742B2 (en) 2001-10-18
EP0915872A1 (en) 1999-05-19
KR20000029637A (ko) 2000-05-25
DE69722003D1 (de) 2003-06-18
CY2483B1 (en) 2005-06-03
ZA976492B (en) 1998-01-29
JP2000516589A (ja) 2000-12-12
BR9711605A (pt) 1999-08-24
CN1226247A (zh) 1999-08-18
SA97180473A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
TR200100189T2 (tr) Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler
TR199900186T2 (xx) H�cre proliferasyonunun engellenmesine y�nelik ikameli/katk�l� bisindolilmaleimidler
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
BR9916746A (pt) Compostos anti-inflamatórios que inibem adesão de célula
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
TR199800815A2 (en) S�lfonilaminokarbonasitler.
ATE375334T1 (de) Harnstoff derivate als entzündungshemmende mittel
TR199900308T2 (xx) Tiyenopirimidinler
ES2133807T3 (es) Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
PT1001930E (pt) Derivados de n-hidroxiformamida como inibidores de metaloproteinases de matriz
ATE233735T1 (de) Neue phenanthridine
PT896533E (pt) Pentafluorobenzenosulfonamidas e analogos
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
NO20004053L (no) Glukokortikoid-selektive antiinflammatoriske midler
DE69021501D1 (de) Anti-entzündende 4-aminophenol-derivate.
DE69723863D1 (de) Chinoline und deren therapeutische verwendung
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
BR9106367A (pt) Acidos e n-hidroxiureias anti-inflamatorias
PT1144365E (pt) Inibidores da adesao de celulas mediada por alfa4beta1
TR199802384T2 (xx) N�rodejeneratif hastal�klar�n tedavisinde yararl� farmas�tik bile�imlerin haz�rlanmas� i�in P-Aminofenol t�revlerinin kullan�m�.
TR199800841A2 (xx) �kame edilmi� 6- ve 7-aminotetrahidroisokinolinkarbon asitleri.
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents